Page last updated: 2024-08-16

ribavirin and Cancer of Cervix

ribavirin has been researched along with Cancer of Cervix in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, L; Gong, Z; Wang, L; Xi, C; Ye, H; Yu, J	1

Other Studies

1 other study(ies) available for ribavirin and Cancer of Cervix

Article	Year
Inhibition of eukaryotic translation initiation factor 4E is effective against chemo-resistance in colon and cervical cancer. Biochemical and biophysical research communications, 2018, 09-18, Volume: 503, Issue:4 Topics: Animals; Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Colonic Neoplasms; Drug Resistance; Drug Synergism; Eukaryotic Initiation Factor-4E; Female; Fluorouracil; Humans; Mice; Paclitaxel; Ribavirin; Uterine Cervical Neoplasms	2018

Article

Year

Inhibition of eukaryotic translation initiation factor 4E is effective against chemo-resistance in colon and cervical cancer.

Biochemical and biophysical research communications, 2018, 09-18, Volume: 503, Issue:4

Topics: Animals; Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Colonic Neoplasms; Drug Resistance; Drug Synergism; Eukaryotic Initiation Factor-4E; Female; Fluorouracil; Humans; Mice; Paclitaxel; Ribavirin; Uterine Cervical Neoplasms

2018